Dr. Ruben Mesa

2022 ASH Conference - Dr. Ruben Mesa, MD

Guidelines & Gaps in MPNs - Dr. Ruben Mesa

Dr. Ruben Mesa Discusses ASCO 2023 Updates from the SIMPLIFY Trials in Myelofibrosis

Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa

Dr. Ruben Mesa on Advancements in Polycythemia Vera

Dr Ruben Mesa Discusses Better Understanding Symptoms in MPNs

Dr. Ruben Mesa - IMPACT@21

Guidelines & Gaps in MPNs - Dr. Ruben Mesa

Dr. Ruben Mesa offers guidance to MPN Patients about the Coronavirus (Covid-19).

7th Annual Women & MPN Conference- Dr. Ruben Mesa

Quantifying the anemia benefit of momelotinib in MF: analysis of data from SIMPLIFY-1 & SIMPLIFY-2

Opening Remarks - Dr. Ruben Mesa

Dr Ruben Mesa explains MPNs in Spanish

MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa

Ruben Mesa, MD - The History of MPNs

Dr Ruben Mesa on Fedratinib’s Impact on Health-Related Quality of Life

MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa

Dr Ruben Mesa on Calculating Health-Related Quality of Life for Patients With MPNs

Dr Ruben Mesa on the Importance of Gauging Quality of Life in MPNs

Dr. Ruben Mesa, MD- Individualized Treatment Plans for MPNs

Dr. Ruben Mesa on the importance of diversity in clinical trials

Dr Ruben Mesa Outlines the Quality of Life Impact of Myelofibrosis

Overview of the clinical management of patients with MF

KSAT Q&A: Dr. Ruben Mesa